// App-Quantinova.ai

455 : Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).

Researchers

Presenter

  • Alison Jane Birtle

Principal Investigators

  • John David Chester

  • Robert J. Jones

  • Ben Jenkins

  • Mark Johnson

  • James WF Catto

  • Thomas Powles

  • Richard T. Bryan

  • Anthony Blacker

  • Prabir R Chakraborti

  • Satinder Jagdev

  • John Wagstaff

  • Anna Tolentino

  • Luke Webster

  • Rebecca Lewis

  • Emma Hall

Medical Centers

  • Rosemere Cancer Centre, Royal Preston Hospital, Preston, United Kingdom

  • Cardiff University, Cardiff, United Kingdom

  • University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom

  • Academic Radiology, The University of Sheffield, Sheffield, United Kingdom,

  • The Royal Free NHS Trust, London, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • University Hospitals of Coventry and Warwickshire, West Midlands, United Kingdom

  • Derby Teaching Hospitals/ NHS Foundation Trust, Derby, United Kingdom

  • St James Institute of Oncology, Leeds, United Kingdom

  • Singleton Hospital, Swansea, United Kingdom

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT01993979

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved